Does MOMELOTINIB Cause Condition aggravated? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Condition aggravated have been filed in association with MOMELOTINIB (Ojjaara). This represents 5.4% of all adverse event reports for MOMELOTINIB.
49
Reports of Condition aggravated with MOMELOTINIB
5.4%
of all MOMELOTINIB reports
3
Deaths
7
Hospitalizations
How Dangerous Is Condition aggravated From MOMELOTINIB?
Of the 49 reports, 3 (6.1%) resulted in death, 7 (14.3%) required hospitalization.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMELOTINIB. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does MOMELOTINIB Cause?
Thrombocytopenia (89)
Death (77)
Drug ineffective (75)
Anaemia (59)
Diarrhoea (51)
Myelofibrosis (51)
Dizziness (41)
Pneumonia (41)
Fatigue (39)
Platelet count decreased (38)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which MOMELOTINIB Alternatives Have Lower Condition aggravated Risk?
MOMELOTINIB vs MOMETASONE
MOMELOTINIB vs MOMETASONE FUROATE
MOMELOTINIB vs MOMETASONE FUROATE\OLOPATADINE
MOMELOTINIB vs MONOMETHYL
MOMELOTINIB vs MONTELUKAST